{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:58:51Z","timestamp":1790276331131,"version":"4.1.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.micpath.2020.104012","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T19:49:09Z","timestamp":1580240949000},"page":"104012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Global estimate of phenotypic and genotypic ganciclovir resistance in cytomegalovirus infections among HIV and organ transplant patients; A systematic review and meta-analysis"],"prefix":"10.1016","volume":"141","author":[{"given":"Taher","family":"Azimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaian","family":"Tavakolian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Pourmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Faghihloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2020.104012_bib1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.TP.0000141364.85454.37","article-title":"Outcome of low-dose ganciclovir for cytomegalovirus disease prophylaxis in renal-transplant recipients","volume":"78","author":"Ahmed","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.micpath.2020.104012_bib2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.12659\/AOT.894694","article-title":"Cytomegalovirus immunoglobulin for prophylaxis and treatment of cytomegalovirus infection in the (val) ganciclovir era: a single-center experience","volume":"20","author":"Lopez","year":"2015","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1432-2277.2010.01101.x","article-title":"Pre\u2010emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus\u2010seropositive kidney\u2010transplant recipients","volume":"23","author":"Weclawiak","year":"2010","journal-title":"Transpl. Int."},{"key":"10.1016\/j.micpath.2020.104012_bib4","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/tid.12507","article-title":"Resistant cytomegalovirus in intestinal and multivisceral transplant recipients","volume":"18","author":"Timpone","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1348-0421.2011.00327.x","article-title":"Human cytomegalovirus UL97 D605E polymorphism has a high prevalence in immunocompetent Japanese infants and children","volume":"55","author":"Tanaka","year":"2011","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2020.104012_bib6","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/TP.0b013e3181a492e8","article-title":"The risk, prevention & outcome of cytomegalovirus after pediatric lung transplantation","volume":"87","author":"Danziger-Isakov","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.micpath.2020.104012_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2011.01.015","article-title":"Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus","volume":"51","author":"Posthuma","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/CMR.13.1.83","article-title":"New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients","volume":"13","author":"Sia","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2020.104012_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.healun.2007.09.012","article-title":"A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome","volume":"26","author":"Reddy","year":"2007","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3062.2001.003003128.x","article-title":"Infectious complications of lung transplantation","volume":"3","author":"Alexander","year":"2001","journal-title":"Transpl. Infect. Dis.: Review article"},{"key":"10.1016\/j.micpath.2020.104012_bib11","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/j.transproceed.2018.08.009","article-title":"Risk factors for the development of cytomegalovirus resistance in solid organ transplantation: a retrospective case-control study","volume":"50","author":"Sandkovsky","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.micpath.2020.104012_bib12","first-page":"805","article-title":"Incidence of ganciclovir resistance in CMV-positive renal transplant recipients and its association with UL97 gene mutations","volume":"16","author":"Aslani","year":"2017","journal-title":"Iran. J. Pharm. Res. (IJPR): IJPR"},{"key":"10.1016\/j.micpath.2020.104012_bib13","series-title":"Transplantation Proceedings","first-page":"1048","article-title":"Epidemiology and outcome of ganciclovir-resistant cytomegalovirus infection after solid organ transplantation: a single transplant center experience in Thailand","author":"Bruminhent","year":"2017"},{"key":"10.1016\/j.micpath.2020.104012_bib14","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1073\/pnas.140123497","article-title":"Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy","volume":"97","author":"Emery","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.micpath.2020.104012_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/AAC.00561-13","article-title":"Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens","volume":"58","author":"Minces","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00705-012-1479-4","article-title":"A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients","volume":"158","author":"Zhang","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib17","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1128\/JCM.00526-07","article-title":"Rapid detection directly from patient serum samples of human cytomegalovirus UL97 mutations conferring ganciclovir resistance","volume":"45","author":"Castor","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2020.104012_bib18","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multidrug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/tid.12537","article-title":"Ganciclovir\u2010resistant cytomegalovirus infection in solid organ transplant recipients: a single\u2010center retrospective cohort study","volume":"18","author":"Young","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib20","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbmt.2016.05.003","article-title":"Cytomegalovirus infection after CD34+-selected hematopoietic cell transplantation","volume":"22","author":"Huang","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib21","article-title":"Molecular analysis of ganciclovir-resistant cytomegalovirus in renal transplant recipients with high viral load","volume":"19","author":"Sohrabi","year":"2016","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.micpath.2020.104012_bib22","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/tid.12317","article-title":"Subtherapeutic ganciclovir (GCV) levels and GCV\u2010resistant cytomegalovirus in lung transplant recipients","volume":"16","author":"Gagermeier","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0399-077X(05)81343-5","article-title":"R\u00e9sistance du cytom\u00e9galovirus au ganciclovir associ\u00e9e \u00e0 une mutation du g\u00e8ne UL97","volume":"25","author":"Alain","year":"1995","journal-title":"Med. Maladies Infect."},{"key":"10.1016\/j.micpath.2020.104012_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1590\/0037-8682-0345-2017","article-title":"HCMV UL97 phosphotransferase gene mutations may be associated with antiviral resistance in immunocompromised patients in Bel\u00e9m, PA, Northern Brazil","volume":"51","author":"Silva","year":"2018","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.micpath.2020.104012_bib25","first-page":"51","article-title":"Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir","volume":"48","author":"Foulongne","year":"2004","journal-title":"Acta Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00002030-200302140-00007","article-title":"Discordant phenotypes and genotypes of cytomegalovirus (CMV) in patients with AIDS and relapsing CMV retinitis","volume":"17","author":"Gilbert","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2020.104012_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00002030-199802000-00001","article-title":"Emergence and prevalence of cytomegalovirus UL97 mutations associated with ganciclovir resistance in AIDS patients","volume":"12","author":"Gilbert","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2020.104012_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/381394","article-title":"Emergence of drug-resistant cytomegalovirus retinitis in the contralateral eyes of patients with AIDS treated with ganciclovir","volume":"189","author":"Imai","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-9394(01)01161-8","article-title":"Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: the Cytomegalovirus and Viral Resistance Study Group Report Number 8","volume":"132","author":"Jabs","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.micpath.2020.104012_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/317931","article-title":"Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis","volume":"183","author":"Jabs","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9394(02)01759-2","article-title":"Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis","volume":"135","author":"Jabs","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.micpath.2020.104012_bib32","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1086\/432012","article-title":"Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis","volume":"192","author":"Jabs","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2217\/fvl-2017-0018","article-title":"Human cytomegalovirus UL54 and UL97 mutations for detection of ganciclovir resistance in congenital infection","volume":"12","author":"Javid","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/tid.12241","article-title":"Cytomegalovirus antiviral resistance: characterization of results from clinical specimens","volume":"16","author":"Kleiboeker","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0002-9394(02)01758-0","article-title":"Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant","volume":"135","author":"Kuo","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.micpath.2020.104012_bib36","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1086\/315851","article-title":"Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis","volume":"182","author":"Liu","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1034\/j.1399-3062.2001.30403.x","article-title":"Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment","volume":"3","author":"Mousavi\u2010Jazi","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jmv.20150","article-title":"Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations","volume":"74","author":"Scott","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib39","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/AAC.39.11.2552","article-title":"Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease","volume":"39","author":"Wolf","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib40","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/324672","article-title":"Rate of emergence of cytomegalovirus (CMV) mutations in leukocytes of patients with acquired immunodeficiency syndrome who are receiving valganciclovir as induction and maintenance therapy for CMV retinitis","volume":"184","author":"Boivin","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib41","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00002030-199806000-00009","article-title":"Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis","volume":"12","author":"Bowen","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.micpath.2020.104012_bib42","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1086\/516446","article-title":"Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients","volume":"175","author":"Erice","year":"1997","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib43","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/515293","article-title":"Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis","volume":"177","author":"Liu","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/fvl-2016-0089","article-title":"Human cytomegalovirus pUL97 drug-resistance mutations in congenitally neonates and HIV-infected, no-drug-treated patients","volume":"12","author":"Mirarab","year":"2017","journal-title":"Future Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/517468","article-title":"Early emergence of ganciclovir-resistant human cytomegalovirus strains in children with primary combined immunodeficiency","volume":"178","author":"Wolf","year":"1998","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib46","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jmv.20127","article-title":"Detection of ganciclovir resistance after valacyclovir\u2010prophylaxis in renal transplant recipients with active cytomegalovirus infection","volume":"73","author":"Alain","year":"2004","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/jac\/dkn521","article-title":"Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus","volume":"63","author":"Allice","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib48","series-title":"Transplantation Proceedings","first-page":"492","article-title":"Cytomegalovirus infection and rates of antiviral resistance following intestinal and multivisceral transplantation","author":"Ambrose","year":"2016"},{"key":"10.1016\/j.micpath.2020.104012_bib49","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1399-3046.2010.01419.x","article-title":"The role of cytomegalovirus infection and disease in pediatric bone marrow transplant recipients in Mexico City in the context of viral drug resistance","volume":"15","author":"Arellano\u2010Galindo","year":"2011","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib50","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1600-6143.2009.02617.x","article-title":"Long\u2010term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients","volume":"9","author":"\u00c5sberg","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-3062.2005.00112.x","article-title":"Clinical impact of ganciclovir\u2010resistant cytomegalovirus infections in solid organ transplant patients","volume":"7","author":"Boivin","year":"2005","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib52","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1086\/382753","article-title":"Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients","volume":"189","author":"Boivin","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib53","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.antiviral.2016.10.016","article-title":"Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: a retrospective study","volume":"138","author":"Campos","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2020.104012_bib54","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/tid.12311","article-title":"The impact of drug\u2010resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL 97 and UL 54 gene mutations","volume":"16","author":"Choi","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib55","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/1348-0421.12043","article-title":"Rapid detection of human cytomegalovirus UL 97 and UL 54 mutations for antiviral resistance in clinical specimens","volume":"57","author":"Daikoku","year":"2013","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.micpath.2020.104012_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5578\/mb.9185","article-title":"Investigation of ganciclovir resistance in CMV UL54 and UL97 gene regions in immunocompromised patients receiving gancyclovir treatment","volume":"49","author":"Delice","year":"2015","journal-title":"Mikrobiyoloji Bulteni"},{"key":"10.1016\/j.micpath.2020.104012_bib57","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V96.9.3286","article-title":"Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes","volume":"96","author":"Eckle","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2020.104012_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib59","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1128\/AAC.45.12.3669-3671.2001","article-title":"Lack of emergence of cytomegalovirus UL97 mutations conferring ganciclovir (GCV) resistance following preemptive GCV therapy in allogeneic stem cell transplant recipients","volume":"45","author":"Gilbert","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib60","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib61","series-title":"Transplantation Proceedings","first-page":"2572","article-title":"Cytomegaloviral infection in solid organ transplant recipients: preliminary report of one transplant center experience","author":"Hryniewiecka","year":"2014"},{"key":"10.1016\/j.micpath.2020.104012_bib62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/j.1600-6143.2005.00866.x","article-title":"A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients","volume":"5","author":"Humar","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1399-3062.2010.00584.x","article-title":"Diversity of antiviral\u2010resistant human cytomegalovirus in heart and lung transplant recipients","volume":"13","author":"Iwasenko","year":"2011","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib64","series-title":"Transplantation Proceedings","first-page":"1140","article-title":"Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in Tehran","author":"Hosseini","year":"2015"},{"key":"10.1016\/j.micpath.2020.104012_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/1060028018760578","article-title":"Demonstration of resistant or wild-type virus in recurrent viremia after ganciclovir-resistant cytomegaloviral infection","volume":"52","author":"Jorgenson","year":"2018","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.micpath.2020.104012_bib66","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.31733","article-title":"Assessment of the human cytomegalovirus UL97 gene for identification of resistance to ganciclovir in iranian immunosuppressed patients","volume":"9","author":"Keyvani","year":"2016","journal-title":"Jundishapur J. Microbiol."},{"key":"10.1016\/j.micpath.2020.104012_bib67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1399-3062.2012.00760.x","article-title":"Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients","volume":"14","author":"Kim","year":"2012","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/338143","article-title":"High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapy","volume":"185","author":"Limaye","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/519941","article-title":"Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients","volume":"45","author":"Li","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib70","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2020.104012_bib71","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2017.03.014","article-title":"Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance","volume":"90","author":"L\u00f3pez-Aladid","year":"2017","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcv.2010.01.009","article-title":"Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis","volume":"47","author":"Martin","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(01)00160-3","article-title":"Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity","volume":"23","author":"Mousavi-Jazi","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31821fad25","article-title":"Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients","volume":"92","author":"Myhre","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.micpath.2020.104012_bib75","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.intimp.2006.07.022","article-title":"The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients","volume":"6","author":"Nogueira","year":"2006","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.micpath.2020.104012_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4067\/S0034-98872010000400005","article-title":"B\u00fasqueda de mutaciones en el gen UL 97 asociadas a resistencia a ganciclovir en citomegalovirus obtenidos desde muestras biol\u00f3gicas de pacientes chilenos","volume":"138","author":"Oyarz\u00fan","year":"2010","journal-title":"Rev. Med. Chile"},{"key":"10.1016\/j.micpath.2020.104012_bib77","first-page":"429","article-title":"Detection of a UL97 gene mutation conferring ganciclovir resistance in human cytomegalovirus: prevalence of the D605E polymorphism in Korean immunocompromised patients","volume":"42","author":"Sung","year":"2012","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.micpath.2020.104012_bib78","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1600-6143.2004.00571.x","article-title":"Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation","volume":"4","author":"Zamora","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib79","series-title":"Transplantation Proceedings","first-page":"2926","article-title":"Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China","author":"Zhou","year":"2006"},{"key":"10.1016\/j.micpath.2020.104012_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1386-6532(99)00004-9","article-title":"Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir","volume":"13","author":"Zhou","year":"1999","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib81","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/135965350901400512","article-title":"Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir","volume":"14","author":"Boivin","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.micpath.2020.104012_bib82","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/infdis\/172.1.239","article-title":"Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates","volume":"172","author":"Chou","year":"1995","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib83","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/517467","article-title":"Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis","volume":"178","author":"Erice","year":"1998","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3851\/IMP1899","article-title":"Failure of pre-emptive treatment of cytomegalovirus infections and antiviral resistance in stem cell transplant recipients","volume":"17","author":"van der Beek","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.micpath.2020.104012_bib85","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2014.08.014","article-title":"Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism","volume":"111","author":"Pilorg\u00e9","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2020.104012_bib86","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcv.2003.11.003","article-title":"Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina","volume":"30","author":"Puch","year":"2004","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1386-6532(99)00031-1","article-title":"Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovir","volume":"13","author":"Abraham","year":"1999","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib88","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1086\/314747","article-title":"Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir","volume":"179","author":"Drew","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1086\/514039","article-title":"Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group","volume":"176","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib90","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2009.06.016","article-title":"Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.micpath.2020.104012_bib91","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0928-0197(93)90012-T","article-title":"Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals","volume":"1","author":"Drew","year":"1993","journal-title":"Clin. Diagn. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib92","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/163.4.716","article-title":"Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection","volume":"163","author":"Drew","year":"1991","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib93","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1053-2498(02)00463-1","article-title":"Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients","volume":"21","author":"Bhorade","year":"2002","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0732-8893(87)90020-4","article-title":"In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovir","volume":"6","author":"Cole","year":"1987","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib95","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1432-2277.2002.tb00109.x","article-title":"Assay of cytomegalovirus susceptibility to ganciclovir in renal and heart transplant recipients","volume":"15","author":"de O\u00f1a Navarro","year":"2002","journal-title":"Transpl. Int."},{"key":"10.1016\/j.micpath.2020.104012_bib96","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1128\/AAC.37.6.1360","article-title":"Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients","volume":"37","author":"Slavin","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2020.104012_bib97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/infdis\/168.2.332","article-title":"Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis","volume":"168","author":"Boivin","year":"1993","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib98","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-0012.1996.tb00743.x","article-title":"Early ganciclovir therapy effectively controls viremia and avoids the need for cytomegalovirus (CMV) prophylaxis in renal transplant patients with cytomegalovirus antigenemia","volume":"10","author":"Gotti","year":"1996","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib99","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/342844","article-title":"Analysis and characterization of antiviral drug\u2013resistant cytomegalovirus isolates from solid organ transplant recipients","volume":"186","author":"Lurain","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0928-0197(98)00043-9","article-title":"A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strains","volume":"11","author":"Prix","year":"1998","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib101","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1172\/JCI45449","article-title":"Cytomegalovirus: pathogen, paradigm, and puzzle","volume":"121","author":"Boeckh","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micpath.2020.104012_bib102","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib103","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0037-86821995000200003","article-title":"Prevalence of cytomegalovirus infection in different patient groups of a urban university in Brazil","volume":"28","author":"Suassuna","year":"1995","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.micpath.2020.104012_bib104","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib105","first-page":"521","article-title":"Infectious complications of solid organ transplantations","volume":"15","author":"Simon","year":"2001","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.micpath.2020.104012_bib106","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation\u2013challenging the status quo","volume":"21","author":"Fishman","year":"2007","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib107","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-152-12-201006150-00003","article-title":"Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation","volume":"152","author":"Palmer","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.micpath.2020.104012_bib108","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.healun.2010.04.022","article-title":"Cytomegalovirus disease among donor-positive\/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis","volume":"29","author":"Mitsani","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.micpath.2020.104012_bib109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/342385","article-title":"Ganciclovir-resistant cytomegalovirus in organ transplant recipients","volume":"35","author":"Limaye","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib111","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1172\/JCI117648","article-title":"Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma","volume":"95","author":"Wolf","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.micpath.2020.104012_bib112","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients","volume":"128","author":"El Chaer","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.micpath.2020.104012_bib113","first-page":"298","article-title":"Cytomegalovirus infection after solid organ transplantation","volume":"1","author":"Paya","year":"2003","journal-title":"Transplant infections"},{"key":"10.1016\/j.micpath.2020.104012_bib114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/rmv.309","article-title":"Prophylaxis for CMV should now replace pre\u2010emptive therapy in solid organ transplantation","volume":"11","author":"Hart","year":"2001","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib115","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/346240","article-title":"Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain","volume":"187","author":"Hamprecht","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micpath.2020.104012_bib117","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/rmv.574","article-title":"Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir","volume":"18","author":"Chou","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micpath.2020.104012_bib118","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.antiviral.2009.10.004","article-title":"A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes","volume":"85","author":"Chevillotte","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2020.104012_bib119","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/171.3.576","article-title":"Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance","volume":"171","author":"Chou","year":"1995","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.micpath.2020.104012_bib120","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1086\/314877","article-title":"Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child","volume":"180","author":"Prix","year":"1999","journal-title":"J. Infect. Dis."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019316110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401019316110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:43Z","timestamp":1760110123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401019316110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":120,"alternative-id":["S0882401019316110"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104012","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global estimate of phenotypic and genotypic ganciclovir resistance in cytomegalovirus infections among HIV and organ transplant patients; A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2020.104012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104012"}}